Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now includes a funding note for 2019 (U.S. NIH Grant/Contract) in the study identifiers, and the revision tag in the page footer has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    IPD data-sharing details and access criteria were added, along with references to study documents and publications, expanding the available resources and data-access options for the Lebrikizumab trial.
    Difference
    100%
    Check dated 2026-08-15T15:49:54.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5 instead of Revision: v3.6.4, indicating a small platform update to the page's underlying framework. There is no indication of changes to the trial content or study details.
    Difference
    0.0%
    Check dated 2026-08-08T11:43:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4.
    Difference
    0.0%
    Check dated 2026-07-25T08:19:45.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3, indicating a newer site build. This update does not modify the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-07-03T22:42:50.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.2, representing a minor software release for the page rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-06-26T23:25:55.000Z thumbnail image

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.